Core Viewpoint - The recent announcement by the World Economic Forum highlights that 8 out of 12 selected "Lighthouse Factories" are Chinese companies, showcasing China's leading position in the digital and intelligent transformation of manufacturing [1][4]. Group 1: Lighthouse Factories Selection - The new list of "Lighthouse Factories" includes 12 companies globally, with 8 being from China, indicating a significant breakthrough in China's manufacturing sector [1]. - The selected Chinese companies include Tongwei Solar, Eaton Electric, Mettler Toledo, Yunnan Baiyao, Hisense Hitachi, and two subsidiaries of Haier, reflecting the advancements in smart manufacturing [1][2]. Group 2: Technological Advancements - Tongwei Solar's factory utilizes automated production lines and big data analysis to achieve precise control in key processes, reducing energy and material waste [2]. - Eaton Electric's facility in Changzhou has implemented 10 Industry 4.0 solutions, resulting in a 26% increase in production efficiency, a 33% reduction in delivery time, and a 55% increase in capacity since its digital transformation began in 2022 [2]. - Mettler Toledo's Changzhou factory has integrated digital technologies deeply into its operations, achieving a 98.4% on-time delivery rate and a 22% reduction in delivery cycles through 49 Industry 4.0 applications [2]. Group 3: Other Notable Chinese Factories - Yunnan Baiyao has applied digital technology for raw material traceability, process optimization, and quality control [3]. - Hisense Hitachi has improved labor efficiency by 63% and reduced defect rates by 57% through over 70 innovative technology applications in welding and logistics [3]. - Haier's factories have achieved mass customization and rapid delivery through modular design and flexible production techniques [3]. Group 4: International Presence - Lenovo's Monterrey manufacturing base in Mexico and Midea's Racha factory in Thailand are also recognized as "Lighthouse Factories," showcasing China's global manufacturing capabilities [3]. - Lenovo's facility has been upgraded continuously over nearly 20 years, while Midea's factory has implemented 72 digital and AI solutions, reducing order delivery times by 43% and customer complaints by 32% [3]. Group 5: Significance of Lighthouse Factories - The "Lighthouse Factory" initiative, a collaboration between the World Economic Forum and McKinsey, represents the pinnacle of digital manufacturing and serves as a model for global manufacturing excellence [4]. - Since the initiative's inception in 2018, the number of Chinese companies selected has been increasing, reflecting the country's proactive approach in the competitive landscape of intelligent manufacturing [4].

Core Viewpoint - Yunnan Baiyao Group Co., Ltd. has announced its 2025 special dividend distribution plan, which was approved at the company's first extraordinary general meeting of shareholders on September 15, 2025 [1][2]. Summary by Sections Dividend Distribution Plan - The approved plan involves distributing a cash dividend of 10.19 RMB (including tax) for every 10 shares held, based on a total share capital of 1,784,262,603 shares, resulting in a total cash dividend amount of 1,818,163,592.46 RMB [1][4]. - The remaining undistributed profits will be reserved for future distribution [1]. Implementation Details - The implementation of the dividend distribution plan is consistent with the proposal approved by the shareholders [2]. - The time frame for implementing the plan does not exceed two months from the date of approval [3]. Key Dates - The record date for the dividend distribution is set for September 23, 2025, and the ex-dividend date is September 24, 2025 [4]. Dividend Recipients - The recipients of the dividend will be all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shenzhen Branch, as of the record date [5]. Distribution Method - Cash dividends for A-share shareholders will be directly credited to their accounts through their securities companies on the ex-dividend date [6]. - The company will bear all legal responsibilities for any discrepancies in the dividend distribution due to changes in shareholders' accounts during the application period [6].

Group 1 - The core point of the article is that Yunnan Baiyao announced a special dividend distribution plan for 2025, which includes a cash dividend of 10.19 yuan per 10 shares (tax included) [2] - The record date for the dividend distribution is set for September 23, 2025, and the ex-dividend date is September 24, 2025 [2]

Core Insights - The World Economic Forum has announced a new batch of lighthouse factories, with six out of twelve selected factories located in China [1] Group 1: Selected Companies - The six Chinese companies recognized as lighthouse factories include Eaton Power Equipment Co., Ltd., Mettler-Toledo International Inc., Tongwei Solar Co., Ltd., Yunnan Baiyao Group Co., Ltd., Qingdao Hisense Hitachi Air Conditioning Systems Co., Ltd., and Haier's washing and refrigeration appliance subsidiaries [1] Group 2: Global Lighthouse Network - The Global Lighthouse Network is an initiative launched by the World Economic Forum in 2018, which has since included 201 leading manufacturing plants and value chains in its community [1]

股票代码：000538 股票简称：云南白药 公告编号：2025-32 云南白药集团股份有限公司 2025 年特别分红权益分派实施公告 本公司及其董事会全体成员保证信息披露内容的真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 云南白药集团股份有限公司（以下简称"公司"或"本公司"）2025 年特别 分红权益分派方案已获 2025 年 9 月 15 日召开的公司 2025 年第一次临时股 东大会审议通过，股东大会决议公告刊登于 2025 年 9 月 15 日的《中国证券 报》《上海证券报》《证券时报》及巨潮资讯网（http://www.cninfo.com.cn）。 现将 2025 年特别分红权益分派情况公告如下： 一、股东大会审议通过权益分派方案情况 1、本公司获股东大会审议通过的2025年特别分红权益分派具体方案为： 以公司现有总股本 1,784,262,603 股为基数，向全体股东每 10 股派发现金红 利 10.19 元（含税），送红股 0 股，不以资本公积金转增股本，本次现金分 红总金额 1,818,163,592.46 元。按照本方案分配比例，以分配方案未来实施 时股权登记日享有利润分配权利 ...

Core Points - The company held its first extraordinary general meeting of shareholders in 2025 on September 15, 2025, with both on-site and online voting options available [3][5] - A total of 1,432 shareholders attended the meeting, representing 1,123,338,901 shares, which is 62.9582% of the total voting shares [6] - The meeting approved two key resolutions: the change of the company's 2025 audit institution and the special dividend plan for 2025, both receiving overwhelming support from shareholders [10][12] Meeting Details - The meeting was convened by the company's 10th Board of Directors and was held at the company's headquarters in Kunming, Yunnan Province [4][5] - Voting was conducted through a combination of on-site and online methods, with specific time slots designated for online voting [3] Attendance - The overall attendance included 1,432 shareholders, with 76 attending in person and 1,356 participating via online voting [6] - Among the attendees, 1,428 were small shareholders, representing 61,451,537 shares, which is 3.4441% of the total voting shares [8] Voting Results - The first resolution regarding the change of the audit institution received 99.9189% approval from the voting shares [9] - The second resolution concerning the special dividend plan was approved with 99.9840% of the voting shares in favor [11] Legal Opinion - The legal opinion provided by Beijing Deheng (Kunming) Law Firm confirmed that the meeting's procedures and resolutions complied with legal and regulatory requirements [13]

北京德恒（昆明）律师事务所 关于云南白药集团股份有限公司 2025 年第一次临时股东大会的 北京德恒（昆明）律师事务所 关于云南白药集团股份有限公司 2025 年第一次临时股东大会的 法律意见 云南白药集团股份有限公司： 北京德恒（昆明）律师事务所（下称"本所"）作为公司的常年法律顾问， 本次指派伍志旭律师、杨杰群律师出席公司 2025 年第一次临时股东大会（以下 简称"本次股东大会"），并按照律师行业公认的业务标准、道德规范及勤勉尽 责精神，对公司提供的与本次股东大会有关的文件资料进行了审查，现根据《公 司法》《证券法》《上市公司股东大会规则》及《公司章程》的规定，就公司本 次股东大会的相关事项出具如下法律意见： 法律意见 北京德恒（昆明）律师事务所 Beijing DeHeng Law Offices (KunMing) 云南省昆明市西山区西园路 126 号"融城优郡"B5 幢 3、4 层 电话（传真）：0871-63172192 邮编:650032 一、关于本次股东大会的召集和召开程序 本次股东大会由公司董事长张文学主持，符合法律、法规及《公司章程》的 规定。 二、关于出席本次股东大会人员的资格 经本所 ...

股票代码：000538 股票简称：云南白药 公告编号：2025-31 云南白药集团股份有限公司 2025年第一次临时股东大会决议公告 （1）现场会议召开时间：2025 年 9 月 15 日上午 9:30。 （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的 时间为 2025 年 9 月 15 日 9:15-9:25，9:30-11:30 和 13:00-15:00；通过深 圳证券交易所互联网投票系统投票的时间为 2025 年 9 月 15 日 9:15-15:00。 2、现场会议召开地点：云南省昆明市呈贡区云南白药街 3686 号云 南白药集团股份有限公司总部白药空间二楼会议室。 重要提示：本公司及董事会全体成员保证信息披露内容的真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 重要提示： 1、本次股东大会未出现否决议案的情形。 2、本次股东大会未涉及变更前次股东大会决议。 一、会议召开和出席情况 （一）会议召开情况 1、召开时间： 2、中小股东出席的总体情况： 3、会议召开方式：本次股东大会以现场表决和网络投票相结合的方 式召开。公司将通过深圳证券交易所交易系统和互联网投票系统 1 / 4 ...

Core Viewpoint - Yunnan aims to develop its traditional Chinese medicine (TCM) industry into a significant economic pillar, targeting a scale of 200 billion yuan by enhancing deep processing and establishing a robust supply chain with leading enterprises like Yunnan Baiyao [1][5][7]. Group 1: Industry Development - Yunnan has a rich variety of medicinal resources, with 8,138 types of medicinal resources identified, accounting for 44.2% of the national total [4]. - The province's TCM market is experiencing a downward trend, with over 60% of monitored varieties showing price declines as of September 2025 [3]. - Despite price volatility, many farmers remain enthusiastic about cultivating medicinal herbs due to higher potential returns compared to traditional crops [3]. Group 2: Economic Transformation - The Yunnan government is focusing on transforming resource advantages into economic benefits through policies that promote the TCM industry [5][6]. - The "Three-Year Action Plan" aims for the TCM industry to maintain its national leadership, with a planting area of around 10 million mu and an annual output of over 1.5 million tons by 2027 [5][6]. Group 3: Supply Chain and Processing - Yunnan Baiyao is implementing a "six unifications" strategy to enhance the TCM supply chain, including unified planting areas and standardized management [7]. - The company has established several production bases for key medicinal herbs, aiming to retain value within the region through fresh processing [7][8]. Group 4: Market Expansion - The trend of "food and medicine homology" is gaining traction, with increasing consumer interest in health products derived from TCM, providing new market opportunities [9][10]. - Yunnan's geographical advantages and the Belt and Road Initiative are expected to enhance its role as a trading hub for TCM in Southeast Asia [11][12]. Group 5: International Trade - Yunnan has recently expanded its import capabilities for medicinal herbs, with significant volumes imported from neighboring countries, addressing domestic supply shortages [12]. - The establishment of new border ports is facilitating the trade of medicinal materials, further integrating Yunnan into international markets [11][12].

Core Viewpoint - Yunnan aims to develop its traditional Chinese medicine (TCM) industry into a "second tobacco industry" with a target of a trillion yuan industry, focusing on deep processing and the role of leading enterprises like Yunnan Baiyao [1][5][6] Industry Overview - Yunnan is recognized as an ideal region for TCM cultivation due to its favorable climate and long history of planting, with a consensus that "without Yunnan medicine, no prescription can be formed" [1] - The province has a significant advantage in medicinal resources, with 8,138 types of TCM resources, accounting for 44.2% of the national total [3] - The TCM market in Yunnan is experiencing a downward trend, with over 60% of monitored varieties expected to see price declines by September 2025 [2][5] Market Dynamics - The price of TCM seeds fluctuates significantly, with variations of 4-5 times, while the price of harvested TCM can vary by 25-30% [2] - The demand for TCM is expected to increase due to the growth of the health industry and the popularity of food-medicine products among younger consumers [1][8] Policy and Development Strategy - The Yunnan provincial government has introduced plans to enhance the TCM industry, including the "Yunnan TCM Planting and Breeding Area Planning (2025-2027)" and the "Three-Year Action Plan for High-Quality Development of Yunnan TCM Industry (2025-2027)" [5][6] - The goal is to maintain a planting area of around 10 million mu, with an annual output of over 1.5 million tons and a total industry chain output value exceeding 200 billion yuan by 2027 [5][6] Company Initiatives - Yunnan Baiyao is actively involved in enhancing the TCM industry by implementing a "six unification" strategy to strengthen the entire supply chain [6][7] - The company has established several production bases and is focusing on digital platforms to facilitate direct supply from the source, with a transaction volume exceeding 1.2 billion yuan [7][8] Product Innovation - Yunnan Baiyao is developing high-value-added products, including natural fragrances and functional cosmetics derived from TCM, to meet the growing consumer demand [8][9] - The trend of food-medicine integration is gaining traction, with companies exploring the potential of TCM products in mainstream markets [9] Trade and Export Opportunities - The establishment of new border ports for TCM imports is expected to enhance trade opportunities, with Yunnan leading the nation in both import volume and value [10][11] - The region's strategic location and participation in initiatives like the Belt and Road are anticipated to further solidify Yunnan's role as a TCM trading hub for South Asia and Southeast Asia [10][11]